{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:17:09Z","timestamp":1789823829787,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T00:00:00Z","timestamp":1467244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T00:00:00Z","timestamp":1467244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hepatoblastoma is the most common liver tumor of early childhood, which is usually characterized by unusual hypervascularity. Recently, long non-coding RNAs (lncRNA) have emerged as gene regulators and prognostic markers in several cancers, including hepatoblastoma. We previously reveal that lnRNA-TUG1 is upregulated in hepatoblastoma specimens by microarray analysis. In this study, we aim to elucidate the biological and clinical significance of TUG1 upregulation in hepatoblastoma. We show that TUG1 is significantly upregulated in human hepatoblastoma specimens and metastatic hepatoblastoma cell lines. TUG1 knockdown inhibits tumor growth and angiogenesis\n                    <jats:italic>in vivo<\/jats:italic>\n                    , and decreases hepatoblastoma cell viability, proliferation, migration, and invasion\n                    <jats:italic>in vitro<\/jats:italic>\n                    . TUG1, miR-34a-5p, and VEGFA constitutes to a regulatory network, and participates in regulating hepatoblastoma cell function, tumor progression, and tumor angiogenesis. Overall, our findings indicate that TUG1 upregulation contributes to unusual hypervascularity of hepatoblastoma. TUG1 is a promising therapeutic target for aggressive, recurrent, or metastatic hepatoblastoma.\n                  <\/jats:p>","DOI":"10.1038\/cddis.2016.143","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T09:05:05Z","timestamp":1467277505000},"page":"e2278-e2278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Targeting long non-coding RNA-TUG1 inhibits tumor growth and angiogenesis in hepatoblastoma"],"prefix":"10.1038","volume":"7","author":[{"given":"R","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G-B","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B-H","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K-R","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,30]]},"reference":[{"key":"BFcddis2016143_CR1","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm.2537","volume":"17","author":"SM Weis","year":"2011","unstructured":"Weis SM, Cheresh DA . Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 2011; 17: 1359\u20131370.","journal-title":"Nat Med"},{"key":"BFcddis2016143_CR2","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1126\/science.aad0862","volume":"349","author":"LB Rivera","year":"2015","unstructured":"Rivera LB, Bergers G . Tumor angiogenesis, from foe to friend. Science 2015; 349: 694\u2013695.","journal-title":"Science"},{"key":"BFcddis2016143_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.molmed.2011.01.015","volume":"17","author":"P Saharinen","year":"2011","unstructured":"Saharinen P, Eklund L, Pulkki K, Bono P, Alitalo K . VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends Mol Med 2011; 17: 347\u2013362.","journal-title":"Trends Mol Med"},{"issue":"Suppl. 1","key":"BFcddis2016143_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000333256","volume":"81","author":"T Sakurai","year":"2011","unstructured":"Sakurai T, Kudo M . Signaling pathways governing tumor angiogenesis. Oncology 2011; 81 (Suppl. 1): 24\u201329.","journal-title":"Oncology"},{"key":"BFcddis2016143_CR5","first-page":"293","volume":"3","author":"E Hiyama","year":"2014","unstructured":"Hiyama E . Pediatric hepatoblastoma: diagnosis and treatment. Transl Pediatr 2014; 3: 293\u2013299.","journal-title":"Transl Pediatr"},{"key":"BFcddis2016143_CR6","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1158\/1538-7445.AM2014-3086","volume":"74","author":"R Kappler","year":"2014","unstructured":"Kappler R, Eichenm\u00fcller M, Trippel F, Strom TM, von Schweinitz D . The genetic landscape of the childhood liver cancer hepatoblastoma. Cancer Res 2014; 74: 3086\u20133086.","journal-title":"Cancer Res"},{"key":"BFcddis2016143_CR7","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/hep.27243","volume":"60","author":"D Jia","year":"2014","unstructured":"Jia D, Dong R, Jing Y, Xu D, Wang Q, Chen L et al. Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex. Hepatology 2014; 60: 1686\u20131696.","journal-title":"Hepatology"},{"key":"BFcddis2016143_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MOP.0000000000000046","volume":"26","author":"P Czauderna","year":"2014","unstructured":"Czauderna P, Lopez-Terrada D, Hiyama E, H\u00e4berle B, Malogolowkin MH, Meyers RL . Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 2014; 26: 19\u201328.","journal-title":"Curr Opin Pediatr"},{"key":"BFcddis2016143_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-biochem-051410-092902","volume":"81","author":"JL Rinn","year":"2012","unstructured":"Rinn JL, Chang HY . Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012; 81: 145\u2013166.","journal-title":"Annu Rev Biochem"},{"key":"BFcddis2016143_CR10","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1038\/bjc.2013.233","volume":"108","author":"S Cheetham","year":"2013","unstructured":"Cheetham S, Gruhl F, Mattick J, Dinger M . Long noncoding RNAs and the genetics of cancer. Brit J Cancer 2013; 108: 2419\u20132425.","journal-title":"Brit J Cancer"},{"key":"BFcddis2016143_CR11","doi-asserted-by":"publisher","first-page":"e85599","DOI":"10.1371\/journal.pone.0085599","volume":"9","author":"R Dong","year":"2014","unstructured":"Dong R, Jia D, Xue P, Cui X, Li K, Zheng S et al. Genome-wide analysis of long noncoding RNA (lncRNA) expression in hepatoblastoma tissues. PloS One 2014; 9: e85599.","journal-title":"PloS One"},{"key":"BFcddis2016143_CR12","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2012.04.031","volume":"57","author":"T-C Shih","year":"2012","unstructured":"Shih T-C, Tien Y-J, Wen C-J, Yeh T-S, Yu M-C, Huang C-H et al. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol 2012; 57: 584\u2013591.","journal-title":"J Hepatol"},{"key":"BFcddis2016143_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP . The multilayered complexity of ceRNA crosstalk and competition. Nature 2014; 505: 344\u2013352.","journal-title":"Nature"},{"key":"BFcddis2016143_CR14","doi-asserted-by":"publisher","first-page":"D239","DOI":"10.1093\/nar\/gks1246","volume":"41","author":"MD Paraskevopoulou","year":"2013","unstructured":"Paraskevopoulou MD, Georgakilas G, Kostoulas N, Reczko M, Maragkakis M, Dalamagas TM et al. DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs. Nucleic Acids Res 2013; 41: D239\u2013D245.","journal-title":"Nucleic Acids Res"},{"key":"BFcddis2016143_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.molcel.2012.05.012","volume":"46","author":"Y Kim","year":"2012","unstructured":"Kim Y, Kim VN . MicroRNA factory: RISC assembly from precursor microRNAs. Mol Cell 2012; 46: 384\u2013386.","journal-title":"Mol Cell"},{"key":"BFcddis2016143_CR16","doi-asserted-by":"publisher","first-page":"6845","DOI":"10.1093\/nar\/gkr330","volume":"39","author":"DW Thomson","year":"2011","unstructured":"Thomson DW, Bracken CP, Goodall GJ . Experimental strategies for microRNA target identification. Nucleic Acids Res 2011; 39: 6845\u20136853.","journal-title":"Nucleic Acids Res"},{"key":"BFcddis2016143_CR17","doi-asserted-by":"publisher","first-page":"e29722","DOI":"10.1371\/journal.pone.0029722","volume":"7","author":"S Yamamura","year":"2012","unstructured":"Yamamura S, Saini S, Majid S, Hirata H, Ueno K, Deng G et al. MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells. PLoS One 2012; 7: e29722.","journal-title":"PLoS One"},{"key":"BFcddis2016143_CR18","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang KC, Chang HY . Molecular mechanisms of long noncoding RNAs. Mol Cell 2011; 43: 904\u2013914.","journal-title":"Mol Cell"},{"key":"BFcddis2016143_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.tcb.2011.04.001","volume":"21","author":"O Wapinski","year":"2011","unstructured":"Wapinski O, Chang HY . Long noncoding RNAs and human disease. Trends Cell Biol 2011; 21: 354\u2013361.","journal-title":"Trends Cell Biol"},{"key":"BFcddis2016143_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.canlet.2013.06.013","volume":"339","author":"X Shi","year":"2013","unstructured":"Shi X, Sun M, Liu H, Yao Y, Song Y . Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 2013; 339: 159\u2013166.","journal-title":"Cancer Lett"},{"key":"BFcddis2016143_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s13277-013-0658-6","volume":"34","author":"M-T Qiu","year":"2013","unstructured":"Qiu M-T, Hu J-W, Yin R, Xu L . Long noncoding RNA: an emerging paradigm of cancer research. Tumor Biol 2013; 34: 613\u2013620.","journal-title":"Tumor Biol"},{"key":"BFcddis2016143_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/jso.23264","volume":"107","author":"Y Han","year":"2012","unstructured":"Han Y, Liu Y, Gui Y, Cai Z . Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder. J Surg Oncol 2012; 107: 555\u2013559.","journal-title":"J Surg Oncol"},{"key":"BFcddis2016143_CR23","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.3748\/wjg.v19.i23.3658","volume":"19","author":"WJ Cao","year":"2013","unstructured":"Cao WJ, Wu HL, He BS, Zhang YS, Zhang ZY . Analysis of long non-coding RNA expression profiles in gastric cancer. World J Gastroenterol 2013; 19: 3658\u20133664.","journal-title":"World J Gastroenterol"},{"key":"BFcddis2016143_CR24","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.7314\/APJCP.2013.14.4.2311","volume":"14","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Geng PL, Yin P, Wang XL, Jia JP, Yao J . Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J Cancer Prev 2013; 14: 2311\u20132315.","journal-title":"Asian Pac J Cancer Prev"},{"key":"BFcddis2016143_CR25","doi-asserted-by":"publisher","first-page":"e1243","DOI":"10.1038\/cddis.2014.201","volume":"5","author":"E Zhang","year":"2014","unstructured":"Zhang E, Yin D, Sun M, Kong R, Liu X, You L et al. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis 2014; 5: e1243.","journal-title":"Cell Death Dis"},{"key":"BFcddis2016143_CR26","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1177\/1535370215622708","volume":"241","author":"J Li","year":"2016","unstructured":"Li J, Zhang M, An G, Ma Q . LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis. Exp Biol Med 2016; 241: 644\u2013649.","journal-title":"Exp Biol Med"},{"key":"BFcddis2016143_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP . A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011; 146: 353\u2013358.","journal-title":"Cell"},{"key":"BFcddis2016143_CR28","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1016\/j.febslet.2015.08.020","volume":"589","author":"J Tan","year":"2015","unstructured":"Tan J, Qiu K, Li M, Liang Y . Double\u2010negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells. FEBS Lett 2015; 589: 3175\u20133181.","journal-title":"FEBS Lett"},{"key":"BFcddis2016143_CR29","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1074\/mcp.M113.035808","volume":"13","author":"P De Antonellis","year":"2014","unstructured":"De Antonellis P, Carotenuto M, Vandenbussche J, De Vita G, Ferrucci V, Medaglia C et al. Early targets of miR-34a in neuroblastoma. Mol Cell Proteomics 2014; 13: 2114\u20132131.","journal-title":"Mol Cell Proteomics"},{"key":"BFcddis2016143_CR30","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/carcin\/bgq066","volume":"31","author":"RT Pang","year":"2010","unstructured":"Pang RT, Leung CO, Ye T-M, Liu W, Chiu PC, Lam KK et al. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 2010; 31: 1037\u20131044.","journal-title":"Carcinogenesis"},{"key":"BFcddis2016143_CR31","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.stem.2013.03.002","volume":"12","author":"P Bu","year":"2013","unstructured":"Bu P, Chen K-Y, Chen JH, Wang L, Walters J, Shin YJ et al. A microRNA miR-34a-regulated bimodal switch targets notch in colon cancer stem cells. Cell Stem Cell 2013; 12: 602\u2013615.","journal-title":"Cell Stem Cell"},{"key":"BFcddis2016143_CR32","first-page":"e194","volume":"3","author":"G Misso","year":"2014","unstructured":"Misso G, Di Martino MT, De Rosa G, Farooqi AA, Lombardi A, Campani V et al. Mir-34: a new weapon against cancer? Mol Ther 2014; 3: e194.","journal-title":"Mol Ther"},{"key":"BFcddis2016143_CR33","doi-asserted-by":"publisher","first-page":"872","DOI":"10.18632\/oncotarget.1825","volume":"5","author":"M Agostini","year":"2014","unstructured":"Agostini M, Knight RA . miR-34: from bench to bedside. Oncotarget 2014; 5: 872.","journal-title":"Oncotarget"},{"key":"BFcddis2016143_CR34","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P . Angiogenesis in life, disease and medicine. Nature 2005; 438: 932\u2013936.","journal-title":"Nature"},{"issue":"Suppl. 3","key":"BFcddis2016143_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000088478","volume":"69","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P . VEGF as a key mediator of angiogenesis in cancer. Oncology 2005; 69 (Suppl. 3): 4\u201310.","journal-title":"Oncology"},{"key":"BFcddis2016143_CR36","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1158\/0008-5472.CAN-11-3406","volume":"72","author":"B Sitohy","year":"2012","unstructured":"Sitohy B, Nagy JA, Dvorak HF . Anti-VEGF\/VEGFR therapy for cancer: reassessing the target. Cancer Res 2012; 72: 1909\u20131914.","journal-title":"Cancer Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2016143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016143","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T04:01:11Z","timestamp":1672804871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2016143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,30]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6]]}},"alternative-id":["BFcddis2016143"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2016.143","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,30]]},"assertion":[{"value":"15 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}